Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 12 citing articles:

Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 135
Epigenetic regulation of human FOXP3+ Tregs: from homeostasis maintenance to pathogen defense
Yi Yue, Yuqing Ren, Chunya Lu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Zinc-Dependent Histone Deacetylases in Lung Endothelial Pathobiology
Rahul Patil, McKenzie E. Maloney, Rudolf Lucas, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 140-140
Open Access | Times Cited: 5
Histone Deacetylase 6 (HDAC6) in Ciliopathies: Emerging Insights and Therapeutic Implications
Zhiyi Wang, Xiaofan Zhu, Zhenzhou Huang, et al.
Advanced Science (2025)
Open Access
A new computational cross-structure-activity relationship (C-SAR) approach applies to a selective HDAC6 inhibitor dataset for accelerated structure development
Shaymaa E. Kassab
Computers in Biology and Medicine (2025) Vol. 192, pp. 110169-110169
Closed Access
Role of Histone Modifications in Kidney Fibrosis
Shengyu Pan, Tianhui Yuan, Yuqi Xia, et al.
Medicina (2024) Vol. 60, Iss. 6, pp. 888-888
Open Access | Times Cited: 3
Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer
Ana Vuletić, Katarina Mirjačić Martinović, Jelena Spasić
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 54-54
Open Access | Times Cited: 7
HDAC6 inhibition disrupts HDAC6-P300 interaction reshaping the cancer chromatin landscape
Michela Gottardi Zamperla, Barbara Illi, Veronica Barbi, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho
Min Liu, Y Zhang, Ping Zhan, et al.
Pharmacological Research (2023) Vol. 198, pp. 107009-107009
Open Access | Times Cited: 6
Identification of glycosyltransferase genes for diagnosis of T-cell mediated rejection and prediction of graft loss in kidney transplantation
Kaifeng Mao, Fenwang Lin, Yige Pan, et al.
Transplant Immunology (2024) Vol. 87, pp. 102114-102114
Open Access | Times Cited: 1
The epigenomic consequences of HDAC6 inactivation reveal a crucial role for P300 suggesting integrated epitherapeutic strategies
Michela Gottardi Zamperla, Barbara Illi, Veronica Barbi, et al.
Research Square (Research Square) (2024)
Open Access
Selective inhibition of HDAC6 by N-acylhydrazone derivative reduces the proliferation and induces senescence in carcinoma hepatocellular cells
Guilherme Álvaro Ferreira‐Silva, Daniel Alencar Rodrigues, Carolina Girotto Pressete, et al.
Toxicology in Vitro (2024) Vol. 99, pp. 105884-105884
Closed Access
Page 1

Scroll to top